| Literature DB >> 36128340 |
Raquel Ruiz1,2, Alfred Vitale1,2, Ann Schwartz1,2, Deborah Ossip1,2,3, Martin S Zand1,2,3,4, Ann Dozier1,2,3, Leonard E Egede5,6.
Abstract
Diversification of the Translational Science workforce is a strategic goal for the National Center for the Advancement of Translational Science (NCATS) program. NCATS has identified the development of translational science education, training, and support for a diverse translational science workforce as key to advancing the growing field of translational science. An annual mixed-methods assessment has been conducted on Common Metrics data submitted by over 60 Clinical & Translational Science Awards (CTSA) programs nationwide and includes metrics addressing recruitment and retention of scientists with particular attention to underrepresented persons and women. This article describes a methodology for the development of From Insights to Action, a resource for guiding program implementation and strategic planning to develop a diverse clinical and translational science workforce. This was informed by the Common Metrics Initiative process and constituted of findings from qualitative interviews of a subset of CTSAs that participated. The dissemination of this guide had several impacts, including providing structural foci for the CTSA Fall 2020 program meeting centered on Diversity, Equity, and Inclusion in translational science; addressing NCATS' goal of workforce diversity; and understanding the number of diverse graduates still engaged in research.Entities:
Keywords: Diversity; clinical research; mentoring; training; translational science; workforce
Year: 2022 PMID: 36128340 PMCID: PMC9453576 DOI: 10.1017/cts.2022.434
Source DB: PubMed Journal: J Clin Transl Sci ISSN: 2059-8661
Semi-structured hub interview protocol
|
What specific strategies did you implement between 2017 and 2018? Provide as much detail as possible. Who was on the team? How were the strategies implemented? Were the strategies focused on scholars, faculty, or the institution? What challenges did you face? How did you address them? How do these strategies impact the future of clinical and translational research? What are you next steps for promoting diversity and inclusion at your CTSA? What recommendations do you have for other hubs? |
Note: During the interview, the institution was asked about the themes identified from the initial qualitative analysis from the Turn-The-Curve plans. The results of this interview led to these products: 1) blogs and 2) webinars.
CTSA: Clinical &Translational Science Awards
Fig. 1.Five themes from interviews translated into blogs and webinars.
Emergent themes / key findings from secondary analysis
|
| |
|---|---|
|
| |
|
| |
|
|
|
|
|
From what departments and cultural backgrounds do program Principal Investigator’s (PIs) represent? In what ways can program alumni take on leadership roles? In what ways do program leaders serve as relatable role models for prospective scholars and trainees? |
|
|
Whose voices are included on the committee in charge of selecting your scholars and trainees? What departments and backgrounds do they reflect? Is there an appropriate space to include a diversity and inclusion advocate and/or a community member? What do you want your scholar or trainee community to look like? Is your committee reflective of these goals? |
|
|
How do mentors become involved with the program? From what departments and backgrounds are they recruited? How are faculty selected or recruited to become mentors? In what ways are alumni encouraged to continue their engagement with the program as role models and mentors to future scholars and trainees? Are there pathways for this transition? |
|
|
In what ways can scholars and trainees engage with community members? Are there formal structures, like community liaisons, to facilitate these connections? In what ways are the needs and voices of the community represented in the program? |
|
|
In what ways can program alumni speak with current scholars and trainees about their experiences? What types of guests are invited to workshops and speaking events? What disciplines and backgrounds do they represent? |
|
|
To what extent does your program participate in early “pathway” initiatives? Are investigators encouraged to pursue diversity supplements for their existing grants? What programmatic opportunities do scholars and trainees have to advance as faculty in your institution? What institutional supports exist to support faculty as they transition from their first R grant to their next? |
|
|
Is your program’s commitment to diversity and representation visible? Where? To whom? In what ways does your grant, website, and program application reflect your commitment to representation? |
Fig. 2.Products from program narratives and interview scripts qualitative analyses (CTSA: Clinical & Translational Science Awards).